<-- nev left start -->

Anthrasafe 20mg Injection

Anthrasafe 20mg Injection
Anthrasafe 20mg Injection
Product Description

Anthrasafe 20mg Injection is indicated for treatment of Kaposi's sarcoma, lymphoma, and acute lymphocytic leukemia. Administered via intravenous route, it shows protein binding ability of about 75% with metabolism in liver. This medicinal formulation works by inhibiting progression of topoisomerase-II which is required for relaxation of supercoils in DNA. This activity of doxorubicin results in prevention of DNA replication which causes death of tumor cells. Offered Anthrasafe 20mg Injection has liposome as a vehicle of administration that helps in increasing effectiveness of the drug and delivering better results. 

Product details

Minimum Order Quantity

1 Vial

Packaging Type

Glass Bottle



Injection Site


Contact Us

Shop No. 3, DDA Market, Vikrant Enclave, Mayapuri, Phase I, New Delhi, Delhi, 110064, India
Phone :+918037302103